Stock Events

Stock Events

M2Bio Sciences 

$0.000300
4
-$0.00-0% Friday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0005
52W Low
0.0001
Volume
156,400
Avg. Volume
44
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecExpected
Q2 2012
Q3 2012
Q1 2013
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.27
-0.18
-0.09
0
Expected EPS
N/A
Actual EPS
-0.0017

Financials

-12,092.31%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
26,000Revenue
-3.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WUHN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.01B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap571.47M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing in the same space as M2Bio Sciences.
Canopy Growth
CGC
Mkt Cap433.71M
Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company, competing in cannabis product development.
Aurora Cannabis
ACB
Mkt Cap181.49M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, directly competing with M2Bio's cannabis interests.
Curaleaf
CURLF
Mkt Cap2.76B
Curaleaf Holdings operates in the medical and wellness cannabis sectors, making it a competitor in the cannabis industry with a focus on health and wellness products.

About

Wuhan General Group (China), Inc., through its various subsidiaries, is engaged in the research, development, and commercialization of a wide array of cannabidiol (CBD)-derived products. These products are sold to pharmacies under the Dr. AnnaRx brand. Additionally, the company is actively pursuing the exploration and development of innovative psilocybin-based therapies intended to assist patients grappling with mental illnesses. Its product line targets a range of medical applications, including but not limited to cancer, psychological disorders, and chronic pain. The company maintains its principal office in Pointe-Claire, Canada.
Show more...
CEO
Ms. Carol Pan
Employees
700
Country
United States
ISIN
US9825691051

Listings

STU
DE
WG9.STU
OTC Link
US
WUHN

0 Comments

Share your thoughts

FAQ

What is M2Bio Sciences stock price today?▼
The current price of WUHN is $0.00 USD — it has decreased by -0% in the past 24 hours. Watch M2Bio Sciences stock price performance more closely on the chart.
What is M2Bio Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange M2Bio Sciences stocks are traded under the ticker WUHN.
Is M2Bio Sciences stock price growing?▼
WUHN stock has fallen by -0% compared to the previous week, the month change is a -0% fall, over the last year M2Bio Sciences has showed a +200% increase.
What were M2Bio Sciences earnings last quarter?▼
WUHN earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is M2Bio Sciences revenue for the last year?▼
M2Bio Sciences revenue for the last year amounts to 26,000 USD.
What is M2Bio Sciences net income for the last year?▼
WUHN net income for the last year is -3.14M USD.
How many employees does M2Bio Sciences have?▼
As of June 23, 2026, the company has 700 employees.
In which sector is M2Bio Sciences located?▼
M2Bio Sciences operates in the Health & Wellness sector.
When did M2Bio Sciences complete a stock split?▼
The last stock split for M2Bio Sciences was on December 28, 2006 with a ratio of 1:2000.
Where is M2Bio Sciences headquartered?▼
M2Bio Sciences is headquartered in Reno, United States.